liraglutide glp 1 analogue Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, Liraglutide, a long-acting cardioprotective glucagon-like

CVS Caremark, Express Scripts, and OptumRx jointly excluded Humira and nearly all branded biosimilars from their standard formularies, opting instead to promote their own private-label biosimilars under portfolio agreements

PMID 39728000

China GLP-1 Receptor Agonist Market Analysis The China GLP-1 receptor agonist market was valued at USD 2.35 billion in 2025, supported by rapid emergence of domestic peptide drug developers, increasing government support for innovative biologics under national healthcare reforms, and expanding local manufacturing capacity for metabolic therapies

Another helpful habit is making protein easy